Beijing, China
August 28, 2008
-
Revenues increased 7.73% to RMB 490.71
million from RMB 455.49 million
-
Gross profit rose 32.29% to RMB 144.09
million from RMB 108.92 million
-
Income from Operations rose 65.77% to RMB
98.38 million from 59.35 million
-
Net income increased 62.98% to RMB 60.12
million from RMB 36.89 million
-
Fully diluted EPS increased 74.67% to RMB
2.62 from RMB 1.50
Origin
Agritech Limited (NASDAQ: SEED) (“Origin” or the “Company”),
a technology-focused supplier of crop seeds in China, today
announced unaudited financial results for the third quarter
ended June 30, 2008. Origin prepares its financial statements in
accordance with generally accepted accounting principles (GAAP)
of the United States.
Financial Results Overview
During the third quarter of fiscal 2008, the
Company generated revenues of RMB 490.71 million (US$71.54
million), an increase of 7.73% from revenue of RMB 455.49
million (US$59.84 million) for the three months ended June 30,
2007. This was mainly due to a 6.2% increase in the average
sales price of our products across all seed types with volumes
also increasing 2.2%.
Corn revenues increased 7.75% year-over-year to
RMB 366.04 million (US$53.37 million) from RMB 339.72 million
(US$44.63 million). This was mainly due to a 10.25% increase in
the average sales price of our products across corn seed types.
Gross margins for the third quarter improved to
29.36%, as compared to 23.91% achieved during the third quarter
of 2007 caused by an increase in the average selling price.
Total operating expenses for the three months
ended June 30, 2008 were RMB 45.71 million (US$6.66 million), a
decrease of 7.79% from RMB 49.58 million (US$6.51 million) in
the same period of the prior year. The decrease was mainly due
to the effective internal controls over daily operating costs
and expenses.
-
Selling and marketing expenses were RMB 16.82
million (US$2.45 million) for the third quarter of 2008,
representing a decrease of 7.95% from RMB 18.27 million
(US$2.40 million) for the same period of the last year,
which was mainly due to the decrease in advertising
expenses. Our marketing focus this year consisted mainly of
setting up more effective and cost efficient field
demonstration lots, and eliminating our spending on
advertising and other media expenditures.
-
General and administrative expenses of RMB
19.06 million (US$2.78 million) for the third quarter ended
June 30, 2008, decreased 4.29% from RMB 19.92 million
(US$2.62 million) for the three months ended June 30, 2007
due to an effective control over daily operating costs and
expenses, which should continue to take further effect over
the next 3 quarters.
-
Research and development expenses during the
quarter were RMB 9.83 million (US$ 1.43 million), as
compared with RMB 11.39 million (US$ 1.50 million) for the
three months ended June 30, 2007. R&D expenditures decreased
slightly this quarter, but it has increased for the
nine-month period as a result of the increased build out of
our in-house biotechnology center at our Beijing
headquarters. We expect to continue building our
capabilities in an efficient, cost effective manner.
Income from operations for the third quarter of
2008 amounted to RMB 98.38 million (US$ 14.34 million) compared
with an operating income of RMB 59.35 million (US$7.80 million)
in the same period in 2007 reflecting a 65.77% increase
year-over-year.
Interest expenses for the third quarter of 2008
were RMB10.31 million (US$1.50 million), representing an
increase of 145.29 % from RMB 4.20 million (US$0.55 million) for
the three months ended June 30, 2007, which was primarily
attributable to the inclusion of the interest expenses on the
convertible debt of RMB 5.51 million (US$0.80 million) in the
third quarter of 2008.
Net income for the third quarter of 2008 rose by
62.98% to RMB 60.12 million (US$ 8.77 million), as compared to
net income of RMB 36.89 million (US$4.85 million) in the same
period a year ago. Earnings per share on a fully diluted basis
were RMB 2.62 (US$0.38), as compared to RMB 1.50 (US$0.20) per
diluted share in the same period one year ago, reflecting a
74.67% year-over-year increase.
Balance Sheet
As of June 30, 2008 and September 30, 2007,
Origin's balance sheet included cash and cash equivalents of RMB
334.66 million (US$48.79 million) and RMB162.31 million
(US$21.66 million), respectively. Investments in US Government
Agency bonds amounted to RMB 12.57 million (US$1.83 million) and
RMB 133.97 million (US$17.88 million), respectively. Net working
capital amounted to RMB 285.96 million (US$ 41.69 million) and
RMB 294.98 million (US$39.37 million), respectively. Total
shareholders' equity increased to RMB 332.38 million (US$48.46
million) as compared to RMB 296.92 million (US$39.63 million)
for September 30, 2007.
Company Update
As the Company moves beyond the 2007 transition year, the
average prices, exclusive of scrap sales, have rebounded and
increased year-over-year by approximately 6.2%. Volume has also
increased 2.2%. In addition to the growth due to the reversal of
industry factors, the Company has also streamlined its marketing
efforts. The lower sales and marketing expense was due to a
focus on more effective on-site demonstration lots for the
Company’s customer base, yielding higher average price and
volumes. The Company intends to increase its efforts in this
regard, by doubling the demonstration lots in FY2008 from 5,000
to 10,000 in FY2009.
Origin also
entered into a
Notes Repurchase Agreement on July 28, 2008 with Citadel Equity
Fund Ltd. providing for the repurchase by the Company from
Citadel of a portion of the Company’s outstanding 1% Guaranteed
Senior Secured Convertible Notes due 2012.
The
Note repurchase provides Origin with the opportunity to increase
equity shareholder value while providing flexibility to its
operations as well as fund its GMO development through
internally generated resources.
GMO Pipeline Update
During the quarter, Origin submitted to the
Ministry of Agriculture (MOA) its final application and all
related documents regarding the Phytase corn product. The
Company is hopeful a final decision will be rendered before the
end of this year. Upon approval, the product would be able to be
sold into the Chinese marketplace. This would mark the first GMO
corn product approved for commercialization in China.
Revenue Guidance
Origin expects that total revenues for the year
ending September 30, 2008 will approximate US$75 - US$80
million. Net income for the year ending September 30, 2008 will
approximate US$0.5 - US$2.0 million.
The net income figure is inclusive of roughly US$
2.65 million dollars in non-cash interest expense from our
convertible debt offering. Excluding this non-cash expense, the
adjusted net income range would be US$3.0 to US$4.5 million. The
Company plans to release guidance for 2009 by FY08 year end.
Founded in
1997 and headquartered in Beijing, Origin Agritech Limited
(NASDAQ: SEED) is one of China’s leading, vertically-integrated
agricultural technology company specializing in agri-biotech
research, development and production to supply the growing
populations of China. Origin develops, grows, processes, and
markets crop seeds to farmers throughout China and parts of
Southeast Asia via a network of approximately 3,800 first-level
distributors and 65,000 second-level distributors and
retailers. The hybrid seed industry is estimated at US$2
billion and that is expected to double by 2010. The Company
currently operates facilities in 30 of China’s 32 provinces as
well as Beijing. Since Origin launched its first entirely
internally developed seed in 2003, the Company has developed and
commercialized an internally developed proprietary seed
portfolio of twelve corn hybrids, twelve rice hybrids and two
canola hybrids as of 2007.
CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except number of share and per
share data)
|
|
Three months ended
June 30, |
|
|
2007 |
|
2007 |
|
2008 |
|
2008 |
|
|
RMB |
|
US$ |
|
RMB |
|
US$ |
|
|
(unaudited) |
|
(unaudited) |
|
(unaudited) |
|
(unaudited) |
|
|
|
|
|
|
|
|
|
Revenues |
|
455,486 |
|
59,838 |
|
490,709 |
|
71,541 |
Cost
of revenues |
|
(346,565) |
|
(45,529) |
|
(346,616) |
|
(50,534) |
|
|
|
|
|
|
|
|
|
Gross
Profit |
|
108,921 |
|
14,309 |
|
144,093 |
|
21,007 |
|
|
|
|
|
|
|
|
|
Operating expenses: |
|
|
|
|
|
|
|
|
Selling and marketing |
|
(18,272) |
|
(2,400) |
|
(16,819) |
|
(2,452) |
General and
administrative |
|
(19,918) |
|
(2,617) |
|
(19,063) |
|
(2,779) |
Research and
development |
|
(11,386) |
|
(1,496) |
|
(9,832) |
|
(1,433) |
|
|
|
|
|
|
|
|
|
Total
operating expenses |
|
(49,576) |
|
(6,513) |
|
(45,714) |
|
(6,664) |
|
|
|
|
|
|
|
|
|
Profit
from operations |
|
59,345 |
|
7,796
|
|
98,379 |
|
14,343 |
Interest expense |
|
(4,201) |
|
(552) |
|
(10,305) |
|
(1,502) |
Share
of earnings in equity investee companies |
|
9,170
|
|
1,205
|
|
3,398
|
|
495
|
Interest income |
|
2,044
|
|
268
|
|
873
|
|
127
|
Other
income |
|
74
|
|
10
|
|
97
|
|
14
|
Changes in the fair value of embedded derivatives |
|
- |
|
- |
|
(2,752) |
|
(401) |
|
|
|
|
|
|
|
|
|
Profit
before income taxes and minority interests |
|
66,432 |
|
8,727
|
|
89,690 |
|
13,076 |
Income
tax expense |
|
|
|
|
|
|
|
|
Current |
|
(5,612) |
|
(737) |
|
(7,210) |
|
(1,051) |
Deferred |
|
(6,745) |
|
(886) |
|
(7,488) |
|
(1,092) |
|
|
|
|
|
|
|
|
|
Income
tax expense |
|
(12,357) |
|
(1,623) |
|
(14,698) |
|
(2,143) |
|
|
|
|
|
|
|
|
|
Profit before minority
interests |
|
54,075
|
|
7,104
|
|
74,992
|
|
10,933
|
Minority interests |
|
(17,187) |
|
(2,258) |
|
(14,872) |
|
(2,168) |
|
|
|
|
|
|
|
|
|
Net income |
|
36,888
|
|
4,846
|
|
60,120
|
|
8,765
|
|
|
|
|
|
|
|
|
|
Net income per share –
basic |
|
1.59
|
|
0.21
|
|
2.62
|
|
0.38
|
|
|
|
|
|
|
|
|
|
Net income per share
– diluted |
|
1.50
|
|
0.20
|
|
2.62
|
|
0.38
|
|
|
|
|
|
|
|
|
|
Shares used in
calculating basic net income per share |
|
23,146,355 |
|
23,146,355 |
|
22,987,272 |
|
22,987,272 |
|
|
|
|
|
|
|
|
|
Shares
used in calculating diluted net income per share |
|
24,646,355 |
|
24,646,355 |
|
22,987,272 |
|
22,987,272 |
|
|
|
|
|
|
|
|
|
CONSOLIDATED
BALANCE SHEETS
(In thousands, except share data)
|
|
September 30, |
|
June 30, |
|
|
2007 |
2007 |
|
2008 |
2008 |
|
|
RMB |
US$ |
|
RMB |
US$ |
|
|
|
|
|
(unaudited) |
(unaudited) |
Assets |
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
|
Cash and cash equivalents |
|
162,314 |
21,663
|
|
334,660 |
48,791
|
Debt securities |
|
133,968 |
17,880
|
|
12,574
|
1,833
|
Accounts receivable, net |
|
2,750
|
367
|
|
123
|
18
|
Due from related parties
|
|
7,384
|
986
|
|
3,928
|
573
|
Advances to suppliers |
|
1,029
|
137
|
|
9,310
|
1,357
|
Advances to growers |
|
24,452
|
3,263
|
|
12,007
|
1,750
|
Inventories |
|
449,207 |
59,952
|
|
391,691 |
57,105
|
Income tax recoverable |
|
1,760
|
235
|
|
1,680
|
245
|
Prepaid expenses and other current assets |
|
11,459
|
1,529
|
|
7,422
|
1,082
|
|
|
|
|
|
|
|
Total current assets |
|
794,323 |
106,012 |
|
773,395 |
112,754 |
Land use rights, net |
|
21,554
|
2,877
|
|
20,556
|
2,997
|
Plant and equipment, net |
|
143,043 |
19,091
|
|
148,419 |
21,638
|
Equity investments |
|
58,882
|
7,858
|
|
62,458
|
9,106
|
Goodwill |
|
16,665
|
2,224
|
|
16,665
|
2,430
|
Due from related parties
|
|
7,325
|
978
|
|
5,574
|
813
|
Acquired intangible assets, net |
|
43,057
|
5,746
|
|
44,281
|
6,456
|
Deferred income tax assets |
|
12,828
|
1,712
|
|
21,248
|
3,098
|
Other assets |
|
13,306
|
1,776
|
|
15,849
|
2,311
|
|
|
|
|
|
|
|
Total assets |
|
1,110,983 |
148,274 |
|
1,108,445 |
161,603 |
|
|
|
|
|
|
|
Liabilities, minority interests and
shareholders’ equity |
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
|
Short-term borrowings and current portion
of long-term borrowings |
|
268,400 |
35,821
|
|
229,940 |
33,523
|
Accounts payable |
|
14,365
|
1,917
|
|
25,916
|
3,778
|
Due to growers |
|
17,811
|
2,377
|
|
68
|
10
|
Due to related parties |
|
4,233
|
565
|
|
10,135
|
1,478
|
Advances from customers |
|
82,187
|
10,970
|
|
130,915 |
19,086
|
Deferred revenues |
|
23,238
|
3,101
|
|
3,280
|
478
|
Income tax payable |
|
39,059
|
5,213
|
|
45,823
|
6,681
|
Other payables and accrued expenses |
|
50,054
|
6,680
|
|
41,358
|
6,030
|
|
|
|
|
|
|
|
Total current liabilities |
|
499,347 |
66,644
|
|
487,435 |
71,064
|
|
|
|
|
|
|
|
Long-term borrowings |
|
1,880
|
251
|
|
940
|
137
|
Convertible notes, net of discount |
|
173,669 |
23,178
|
|
172,290 |
25,119
|
Embedded derivatives-redemption feature |
|
86,937
|
11,603
|
|
59,125
|
8,620
|
Other long-term liabilities |
|
3,458
|
461
|
|
3,658
|
533
|
|
|
|
|
|
|
|
Total liabilities |
|
765,291 |
102,137 |
|
723,448 |
105,473 |
Minority interests |
|
48,775
|
6,510
|
|
52,615
|
7,671
|
Commitments and contingencies |
|
|
|
|
|
|
Shareholders’ equity: |
|
|
|
|
|
|
Preferred stock (no par value;1,000,000 shares
authorized, none issued) |
|
-
|
-
|
|
- |
- |
Common
stock (no par value; 60,000,000 shares authorized,
22,974,059 shares issued and outstanding as of
September 30, 2007, and 23,013,702 shares issued and
outstanding as of June 30, 2008, respectively) |
|
-
|
-
|
|
-
|
-
|
Additional paid-in capital |
|
377,324 |
50,359
|
|
386,462 |
56,343
|
Retained earnings (deficit) |
|
(41,404) |
(5,526) |
|
(26,421) |
(3,852) |
Treasury stock at cost (498,851 shares) |
|
(29,377) |
(3,921) |
|
(29,377) |
(4,283) |
Accumulated other comprehensive gain
(loss) |
|
(9,626) |
(1,285) |
|
1,718
|
251
|
|
|
|
|
|
|
|
Total shareholders’ equity |
|
296,917 |
39,627
|
|
332,382 |
48,459
|
|
|
|
|
|
|
|
Total liabilities, minority interests and
shareholders’ equity |
|
1,110,983 |
148,274 |
|
1,108,445 |
161,603 |
|
|